Glutathione S-transferases (GSTs) are a family of enzymes involved in the detoxification of a wide range of chemicals including chemical carcinogens. Human cytosolic GSTs are divided into four major classes; α, µ, π and θ. This study was performed to evaluate the influence of age and gender on the GST isoenzyme expression and glutathione (GSH) content in lymphocytes. Blood was collected from 124 healthy controls, which were divided into age groups of 20-40 years (21 females, 20 males), 40-60 years (20 females, 21 males) and 60-80 years (20 females, 22 males). Lymphocytes were isolated by density centrifugation on Histopaque-1077. After homogenization, cytosolic fractions were isolated. Herein, GST isoenzyme levels were determined by densitometrical analysis of western blots after immunodetection with monoclonal antibodies. Total GSH content was determined by high performance liquid chromatography after conjugation with monobromobimane. Spearman rank correlation and Wilcoxon rank sum tests were used for statistical evaluation. Lymphocytic GSTµ and π levels were not correlated with age or gender. GSTα was not detectable in lymphocytes. GSH contents were not different in males and females, but decreased with age in both males and females. In age group 60-80, GSH content was significantly lower as compared with age groups 20-40 and 40-60 in both sexes. Since high GSH is an essential factor in the detoxification of many compounds, these data indicate that the detoxification potential of the GSH/GST system in lymphocytes may decrease with age in man.
Little is known about the differences in GST and GSH expression between men and women. Also data on GST and GSH levels with respect to aging in humans are scarce. Loguercio et al. (8) showed that GSH content in body and antrum of the stomach decreased with age. They did not find a sex dependency in GSH content. To obtain information of the lymphocytic GSH/GST system during aging, we investigated GST isoenzyme levels and GSH contents in human lymphocytes from 124 healthy subjects, aged 20-80 years.
Blood was collected by venapuncture into sterile siliconized EDTA K3 10 ml vacutainer tubes (Beckton Dickinson, San Jose, CA). Controls were divided into three age groups; 20-40 years (21 females, 20 males), 40-60 years (20 females, 21 males) and 60-80 years (20 females, 22 males). Lymphocytes were isolated by density centrifugation on Histopaque-1077, according to the manufacturers instructions (Sigma diagnostic, St Louis, MO). Lymphocytes were pelleted and stored at -20°C until use. For preparation of cytosolic fractions, lymphocytes were thawed slowly, homogenized in 100 µl of 20 mM Tris-HCl buffer pH 7.4, containing 1 mM dithiothreitol using a glass/glass potter. Homogenates were centrifuged at 12 000 g (4°C) for 20 min. Aliquots of the supernatant were stored at -20°C until use. The investigations were approved by the local ethical committee on human experimentation.
Protein was assayed in triplicate by the method of Lowry et al. (9) , using bovine serum albumin as a standard. Specific GST isoenzyme levels were determined as described previously (10) . In short, cytosolic fractions were subjected to SDS-PAGE [11% acrylamide (w/v)], and subsequently to western blotting, using a semi-dry blotting system (Novablot II, Pharmacia, Uppsala, Sweden). Western blots were incubated with monoclonal antibodies against human GST classes α, µ and π. Class α antibodies react with human GST A1-1, GST A1-2 and GST A2-2 (10). Class µ antibodies recognize human GST M1a-1a, GST M1a-1b and GST M1b-1b (11, 12) . Class π antibodies react with human GST P1-1 (13) . The specific binding of the monoclonal antibodies to the isoenzymes was demonstrated by incubation with peroxidase-conjugated rabbit anti-mouse immunoglobulins (Dakopatts, Glostrup, Denmark) and subsequent staining with 4-chloro-1-naphthol and hydrogen peroxide. Staining intensity on the immunoblots was quantified using a laser densitometer (Ultroscan XL, LKB, Bromma, Sweden). Known amounts of purified GSTs were run in parallel with the experimental samples and served as standards for the calculation of the isoenzyme levels in the cytosolic fractions. The detection limit of this assay is~50 ng/mg protein. Total GSH was quantified by high performance liquid chromatography after reaction with monobromobimane, as described previously (14) . In this assay, oxidized GSH present is reduced by adding sodium borohydride to the reaction mixture. A Spearman rank correlation test was used to correlate lymphocytic GSH content and GST isoenzyme expression with age and gender. A Wilcoxon rank sum test was used to assess statistical significance of differences between age GSH content and GST isoenzyme levels in lymphocytes were determined as described in the text. Values are given as mean Ϯ SEM. Ranges are indicated in parentheses. ND, not detectable. Wilcoxon rank sum test was used for statistical evaluation: *P Ͻ 0.02, **P Ͻ 0.005 and ***P Ͻ 0.002 as compared with age group 60-80 years.
groups. Table I shows the GSH contents and GST isoenzyme levels of all age groups studied. GSTα was not detectable in lymphocytes. In 54 (44%) of the samples, no GSTµ protein was found, in 51% (60% males, 43% females) of the age group 20-40 years, in 34% (38% males, 30% females) of the age group 40-60 years and in 45% (41% males, 50% females) of age group 60-80 years. GSTµ null phenotype was not related to gender or age. GSTπ expression was equally distributed among the different age groups, as well as in males and females. GSH content in lymphocytes was similar in male and female controls, but expression declined with age: females R s ϭ -0.36 (95% CI -0.56-0.12; P ϭ 0.004); males R s ϭ -0.42 (95% CI -0.61-0.20; P ϭ 0.0005). This significant decline in GSH content with age persisted when males and females were combined: R s ϭ -0.39 (95% CI -0.53-0.23; P Ͻ 0.0001). GSH content in age group 60-80 years was significantly reduced as compared with the age groups 20-40 and 40-60 years in both sexes, whereas no difference was observed when comparing GSH contents in age groups 20-40 and 40-60 years.
GSTs are involved in the protection against potentially harmful chemical compounds (1) . Little data are available concerning age-related changes in the levels of GSH and GST isoenzymes in humans. This may be relevant with respect to the possible role of the GSH/GST system in the enhanced cancer rates at increased age. We now showed that the expression of the GSTα, µ and π isoenzymes in human lymphocytes did not change with age, although in females there was a tendency for lower levels of GSTπ at older age (P ϭ 0.06; 20-40 versus 60-80 year age group). No genderrelated effects were found. Unfortunately, due to lack of sufficient material we were unable to measure GST enzyme activity and levels of the most recently discovered GSTφ forms. Cebalos-Picot et al. (15) demonstrated a negative correlation between age and GST activity (R ϭ 0.58, P Ͻ 0.001) in human erythrocytes (120 females, 65 males), but they found no gender-related differences.
Several studies have suggested that GSH might be a critical factor in protecting cells and organs against toxicity and disease, since GSH as an important factor in the GST/ GSH peroxidase systems is involved in the detoxification of xenobiotics, carcinogens, free radicals and peroxides (1) . However, no information is available on the variation of GSH in lymphocytes in relation to gender and age in healthy subjects. We noticed no differences in GSH levels of human lymphocytes between males and females. Similar results were found previously in human blood by Richie et al. (16) (19) , who found a significant increase (P Ͻ 0.001) in the proportion of elderly individuals with low blood GSH values compared with younger adults. Also plasma GSH levels in Chinese male and female volunteers were found to decrease with increasing age (18) . Loguercio et al. (8) showed that GSH content in body and antrum of the stomach decreased with age.
In summary, we demonstrated that GST expression in human lymphocytes was not related to sex or age. GSH content was similar in males and females and decreased with age in both sexes. Since GSH is correlated with protection against cellular or cytogenetic damage, reduction of GSH content during aging may be a factor of relevance for the increased risk of developing diseases such as cancer at an older age.
